{"id":"https://openalex.org/W4411876166","doi":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","title":"Cost-Effectiveness of Oseltamivir and Favipiravir in Covid-19 Patients: a Cost-Effectiveness Analysis Study in a Hospital","display_name":"Cost-Effectiveness of Oseltamivir and Favipiravir in Covid-19 Patients: a Cost-Effectiveness Analysis Study in a Hospital","publication_year":2025,"publication_date":"2025-07-01","ids":{"openalex":"https://openalex.org/W4411876166","doi":"https://doi.org/10.25077/jsfk.12.1.29-35.2025"},"language":"en","primary_location":{"id":"doi:10.25077/jsfk.12.1.29-35.2025","doi":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","is_oa":true,"landing_page_url":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","pdf_url":"https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/download/1698/600","source":{"id":"https://openalex.org/S4210196544","display_name":"Jurnal Sains Farmasi & Klinis","issn_l":"2407-7062","issn":["2407-7062","2442-5435"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315203","host_organization_name":"Ikatan Apoteker Indonesia","host_organization_lineage":["https://openalex.org/P4310315203"],"host_organization_lineage_names":["Ikatan Apoteker Indonesia"],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jurnal Sains Farmasi & Klinis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/download/1698/600","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031083010","display_name":"Yusransyah Yusransyah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275247","display_name":"Sekolah Tinggi Ilmu Kesehatan Salsabila Serang","ror":"https://ror.org/037xa2m72","country_code":"ID","type":"education","lineage":["https://openalex.org/I4405275247"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Yusransyah Yusransyah","raw_affiliation_strings":["Pharmacy Study Program, Sekolah Tinggi Ilmu Kesehatan Salsabila Serang, Banten, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Study Program, Sekolah Tinggi Ilmu Kesehatan Salsabila Serang, Banten, Indonesia","institution_ids":["https://openalex.org/I4405275247"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064915793","display_name":"Baha Udin","orcid":"https://orcid.org/0009-0008-1399-4186","observed_orcids":["https://orcid.org/0009-0008-1399-4186"]},"institutions":[{"id":"https://openalex.org/I4405275247","display_name":"Sekolah Tinggi Ilmu Kesehatan Salsabila Serang","ror":"https://ror.org/037xa2m72","country_code":"ID","type":"education","lineage":["https://openalex.org/I4405275247"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Baha Udin S.farm","raw_affiliation_strings":["Pharmacy Study Program, Sekolah Tinggi Ilmu Kesehatan Salsabila Serang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Study Program, Sekolah Tinggi Ilmu Kesehatan Salsabila Serang","institution_ids":["https://openalex.org/I4405275247"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405275247"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"1","first_page":"29","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9660000205039978},{"id":"https://openalex.org/keywords/oseltamivir","display_name":"oseltamivir","score":0.9950000047683716},{"id":"https://openalex.org/keywords/favipiravir","display_name":"favipiravir","score":1.0},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9829999804496765},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8270000219345093},{"id":"https://openalex.org/keywords/average-cost-effectiveness-ratio","display_name":"average cost-effectiveness ratio","score":0.8989999890327454},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6909999847412109},{"id":"https://openalex.org/keywords/medical-consumables","display_name":"medical consumables","score":0.6179999709129333},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C2779772310","wikidata":"https://www.wikidata.org/wiki/Q16934561","display_name":"Favipiravir","level":5,"score":0.954796314239502},{"id":"https://openalex.org/C2780374985","wikidata":"https://www.wikidata.org/wiki/Q211509","display_name":"Oseltamivir","level":5,"score":0.7791597843170166},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6237672567367554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5081629753112793},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5071427822113037},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.480618417263031},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4438353478908539},{"id":"https://openalex.org/C2983335822","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost analysis","level":2,"score":0.428510844707489},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.1823103427886963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14507997035980225},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.09785950183868408},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.09390455484390259},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.06201070547103882},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25077/jsfk.12.1.29-35.2025","doi":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","is_oa":true,"landing_page_url":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","pdf_url":"https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/download/1698/600","source":{"id":"https://openalex.org/S4210196544","display_name":"Jurnal Sains Farmasi & Klinis","issn_l":"2407-7062","issn":["2407-7062","2442-5435"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315203","host_organization_name":"Ikatan Apoteker Indonesia","host_organization_lineage":["https://openalex.org/P4310315203"],"host_organization_lineage_names":["Ikatan Apoteker Indonesia"],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jurnal Sains Farmasi & Klinis","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25077/jsfk.12.1.29-35.2025","doi":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","is_oa":true,"landing_page_url":"https://doi.org/10.25077/jsfk.12.1.29-35.2025","pdf_url":"https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/download/1698/600","source":{"id":"https://openalex.org/S4210196544","display_name":"Jurnal Sains Farmasi & Klinis","issn_l":"2407-7062","issn":["2407-7062","2442-5435"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315203","host_organization_name":"Ikatan Apoteker Indonesia","host_organization_lineage":["https://openalex.org/P4310315203"],"host_organization_lineage_names":["Ikatan Apoteker Indonesia"],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jurnal Sains Farmasi & Klinis","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411876166.pdf","grobid_xml":"https://content.openalex.org/works/W4411876166.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W2765764881","https://openalex.org/W2794394875","https://openalex.org/W2811493811","https://openalex.org/W3096291340","https://openalex.org/W3097150981","https://openalex.org/W4205349464","https://openalex.org/W4225143846","https://openalex.org/W4285418002","https://openalex.org/W4312972795","https://openalex.org/W4385519978"],"related_works":["https://openalex.org/W7115692861","https://openalex.org/W6893465515","https://openalex.org/W7064628356","https://openalex.org/W4205661677","https://openalex.org/W4392304948","https://openalex.org/W4389965439","https://openalex.org/W4409789632","https://openalex.org/W4401152990","https://openalex.org/W4385558427","https://openalex.org/W4320913127"],"abstract_inverted_index":{"The":[0,44,72,94,156],"COVID-19":[1,26,62],"pandemic":[2],"poses":[3],"not":[4],"only":[5],"a":[6],"threat":[7],"to":[8,12,41,50],"health":[9],"but":[10],"also":[11],"the":[13,52,67,84,101,105,116,133,136,145,148,161,167,171,178,186,193],"global":[14],"economy,":[15],"including":[16],"healthcare":[17],"costs.":[18],"Although":[19],"there":[20,28,139],"is":[21,189],"no":[22,141],"specific":[23],"drug":[24],"for":[25,61],"patients,":[27],"are":[29],"antiviral":[30,55],"drugs":[31],"such":[32],"as":[33],"oseltamivir":[34,58,117,151,194],"and":[35,59,89,150],"favipiravir":[36,60,106,149,187],"that":[37,100,160,169,185],"can":[38,182],"be":[39,183],"used":[40,75],"treat":[42],"COVID-19.":[43],"purpose":[45],"of":[46,66,96,104,128,135,147,163],"this":[47,77,97],"study":[48,78,98],"was":[49,79,113,140,166],"determine":[51],"most":[53],"cost-effective":[54,191],"therapy":[56],"between":[57,144],"patients":[63],"in":[64,69,76],"one":[65],"hospitals":[68],"Banten":[70],"province.":[71],"pharmacoeconomic":[73],"method":[74],"cost-effectiveness":[80],"analysis":[81],"by":[82],"calculating":[83],"Average":[85],"Cost-Effectiveness":[86,91],"Ratio":[87,92],"(ACER)":[88],"Incremental":[90],"(ICER).":[93],"results":[95,134],"showed":[99,159],"ACER":[102],"value":[103,127,154],"group":[107,118,188],"(IDR":[108,119],"364,010":[109],"(n":[110,121],"=":[111,122],"7))":[112],"lower":[114],"than":[115,192],"431,744":[120],"7)),":[123],"with":[124],"an":[125],"ICER":[126],"IDR":[129],"60,605.":[130],"Based":[131,176],"on":[132,174,177],"Mann-Whitney":[137],"test,":[138],"significant":[142],"difference":[143],"costs":[146],"groups":[152],"(p":[153],"0.940).":[155],"sensitivity":[157],"test":[158],"cost":[162,168],"medical":[164],"consumables":[165],"had":[170],"greatest":[172],"impact":[173],"cost-effectiveness.":[175],"calculation":[179],"results,":[180],"it":[181],"concluded":[184],"more":[190],"group.":[195]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}